Comparison of Otonomy Inc. (OTIC) and Intec Pharma Ltd. (NASDAQ:NTEC)

As Biotechnology businesses, Otonomy Inc. (NASDAQ:OTIC) and Intec Pharma Ltd. (NASDAQ:NTEC), are affected by contrast. This especially applies to their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation.

Earnings Valuation

Table 1 shows the gross revenue, earnings per share and valuation for Otonomy Inc. and Intec Pharma Ltd.

Profitability

Table 2 represents Otonomy Inc. (NASDAQ:OTIC) and Intec Pharma Ltd. (NASDAQ:NTEC)’s return on assets, net margins and return on equity.

Analyst Recommendations

In next table is given Otonomy Inc. and Intec Pharma Ltd.’s ratings and recommendations.

Otonomy Inc.’s upside potential is 86.57% at a $5 consensus price target.

Insider Institutional Ownership

The shares of both Otonomy Inc. and Intec Pharma Ltd. are owned by institutional investors at 66.1% and 39.64% respectively. About 0.29% of Otonomy Inc.’s share are owned by insiders. Competitively, 11.81% are Intec

... read more at: https://finheadlines.com/2019/04/16/comparison-of-otonomy-inc-otic-and-intec-pharma-ltd-nasdaqntec/

by